Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Breast CancerCancer

Interventions

DRUG

larotaxel

IV infusion on Day 1 of a 21-day cycle

DRUG

capecitabine

oral, twice daily, Day 1-Day 14 of a 21-day cycle

Trial Locations (2)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, Paris